Company intelligence / Profile preview

Sunij Pharma

Ahmedabad, Gujarat, India

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Sunij Pharma manufactures and markets a range of small molecule generic pharmaceuticals commercialized primarily in India, including anti-tuberculosis, cardiovascular, anti-inflammatory, anti-asthmatic, anti-bacterial, and steroid products. It holds WHO-GMP and ISO-9001 certifications; several medicines are widely available on market, with contract manufacturing for multinational brands. There is no evidence of novel clinical-stage programs or recent clinical trial data.

Therapeutic areas: ImmunologyRheumatologyInfectious DiseasesGastroenterologyPulmonologyCardiovascularNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Contract manufacturing for multinationals

Beyond the preview

Go deeper on Sunij Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sunij Pharma.

Explore the full profile